NO | ምርቶች | CAS የለም | ቁልፍ የጥራት አመላካች | |||
ንፅህና | ማክስ. ርኩሰት | ጠቅላላ ፈሳሽ ቀሪ | እርጥበት | |||
1 | Fmoc-β-al-አላው-አል - ኦህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
2 | FMOC-D-AL-D-ALA-ALA- oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
3 | Fmoc-β-al-d-w-bala -h | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
4 | FMOC-ARG (PBF) -ራክ (PBF) -ህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
5 | FMOC-β-al-ALA-ARG (PBF) -ህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
6 | የ FMOC-D-A-ARG (PBF) - -D-ARG (PBF)-ho | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
7 | FMOC-β-AL-D-ARG (PBF) -ህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
8 | FMOC-HOMOGG (PBF) - homeg (PBF) -ህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
9 | FMOC-β-al-hal-hoorgg (PBF) -ህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
10 | FMOC-ASN (TRT) - -AN (TRT)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
11 | Fmoc--al-funn (trt) -..ህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
12 | FMOC-ASP (ኦቶቢ) -አንድ (ኦ.ቢብ) -ህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
13 | FMOC-β-β-Al-ASP (ኦውቡ) -ህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
14 | FMOC-CYS (TTT) - መጫወቻዎች (trt) - OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
15 | FMOC-β-β-al-als-cys (trt) | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
16 | FMOC-CYS (ኤኬኤም) -ሲ (ኤክኤች)-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
17 | FMOC-β-β-al-als-cys (acm)-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
18 | FMOC-GLN (TTT) - -GLN (TRT)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
19 | Fmoc-β-al-al-gln (trt) - | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
20 | FMOC-GLU (OTBB) - ጎሊ (ኦውቡ) -ህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
21 | Fmoc-β-al-go-glu (ኦቶቢ) -ሂህ .h2O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
22 | Fmoc-β-alal-gly-ኦህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
23 | FMOC - የእሱ (TTT) -አስ (trt) | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
24 | Fmoc-β-al-Al-Al-TRT)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
25 | FMOC-ILE- ile-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
26 | Fmoc-β-al-al-ile-ኦ? | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
27 | Fmoc-ሊሉ-ሊቱ-ኦህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
28 | FMOC-β-al-la-Mau- ኦ? | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
29 | Fmoc-d-Luu-d-Mau-ኦህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
30 | FMOC-β-al-d-deu-ኦህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
31 | FMOC-LES (BOC) - ዋልታዎች (BOC)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
32 | FMOC-β-al-lo-les (BOC) -ህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
33 | FMOC-LES (ALLOC) - alls (አልሎክ) -ህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
34 | FMOC-β-al-lo-les (አልሎክ) -ህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
35 | FMOC የተገናኘ-ተገናኝ-ኦህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
36 | Fmoc-β--አላው-ተገናኝ-ኦህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
37 | FMOC-OrN (BOC) - (BOC) - OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
38 | Fmoc-β-al-Al-ON (BOC) -ህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
39 | FMOC-PHA-PHO-ኦህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
40 | Fmoc-β-al-fo-ph-ኦህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
41 | Fmoc-d-ph-d-p-ph-ኦህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
42 | Fmoc-β-al-d-p-hi -h | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
43 | ኤፍ.ኤም.ሲ. ፕሮፌሰር ፕሮፌሰር | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
44 | Fmoc-β-al-al-Pro-ኦህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
45 | FMOC-SELE (TUBE) - ሰፈር (ታውቡ) -ህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
46 | Fmoc-β-al-al-shab) - << << <<> | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
47 | FMOC-SAT (TRT) -አስተያደር (trt) | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
48 | FMOC-β-al-ALA-SOT (TRT)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
49 | FMOC-MORE (TUBE) - ther (tabu) - | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
50 | FMOC-β-al-hal-hard (tabu) --ህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
51 | FMOC-TRP (BOC) - TRRP (BOC) -ህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
52 | FMOC-β-al-th-TRP (BOC) -ህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
53 | የ FMOC-D-TRP (BOC) -D-TRP (BOC)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
54 | FMOC-β-AL-D-TRP (BOC) -ህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
55 | FMOC-TYR (TUBE) - Thyr (tabu) -..ሁ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
56 | FMOC-β-β-al-tyr (tabu) --ህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
57 | FMOC-D-TYR (ET) -D-TYR (et) | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
58 | FMOC-β-al-d-Tyr (eth) --ህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
59 | FMOC-TYR (ME) - - yyr (እኔ) - ho | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
60 | ኤፍ.ኤም.ሲ-β-β-al-tyr (እኔ) - ho | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
61 | Fmoc-vils-ቫል-ቫል - ኦህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
62 | Fmoc-β-β-alo-va-va - ኦህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
63 | የ FMOC-D-C- C- D-ኦ-ኦ-ኦው | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
64 | Fmoc-β-al-d-d-di-ኦ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
65 | Fmoc-β-al-s-dab-ኦህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
66 | FMOC- (3- ኔፍጽል) -ዲ-አቫ) 2 -h | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
67 | Fmoc-β-β-al -3- (2-NEPHYLY) -D-ALA-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
68 | FMOC- (3- pyridinithlyl) -D-ALA) 2 -h | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
69 | FMOC-β-β-al -3- (3-ፒሪዲይይይ) -D-AL-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
70 | FMOC- (4-ክሎሮ-ዲ-ፓይ) 2 -h | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
71 | Fmoc-β-al -7-CHORO-D-P-pher-ኦህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
72 | FMOC- (D-4 ah (tarucbm (TATUCUBM) 2 -h | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
73 | FMOC-β--AL-D-4 aphፍ (taruucbm)-ho | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
74 | FMOC-APH (l-ard) - APH (l-ard) -hh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
75 | Fmoc-β-al-APH (l-ard)-ho | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
76 | ኤፍ.ኤም.ኤስ. (IRP, BCOC) - elps (IRP, BOC)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
77 | FMOC-β-al-lo-les (iPR, BCOC) -ህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
78 | FMOC-β-al-ALA-AEA-ኦ? | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
79 | ኤፍ.ሲ.ሲ-አይቢ-አይቢብ - ኦህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
80 | FMOC-β-al-Alib-ኦህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
81 | FMOC-Arg-ኦህ | 91000-69-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
82 | ኤች-አርግ (PBF) -ህ | 200115-86-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
83 | FMOC-D-ARG-OH | 130752-32-38 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
84 | HD-ARG (PBF) -ህ | 200116-81-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
85 | FMOC-HOMOGGY-OH OH.HCL | 20817445-14-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
86 | ኤች-ሆሞራግ (PBF) -ህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
87 | Fmoc-d-hoorogg-ኦህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
88 | HD-HOOMGG (PBF) -ህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
89 | FMOC-ASN-ኦህ | 71989-16-7-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
90 | ኤች-አስጊ (TRT) - | 132388-58-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
91 | FMOC-ASP-ኦው | 119062-05-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
92 | ኤች-ቶች (ኦውቡ) -ህ | 3057-74-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
93 | Fmoc-cyes-ኦህ | 135248-89-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
94 | ኤች-ቶች (trt) | 2799/7/7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
95 | ኤች-ቶች (acm)-ho.hcl | 28798-28-9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
96 | FMOC-gln -h | 71989-20-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
97 | ኤች-ግልፍ (trt) | 10274-84-28- | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
98 | Fmoc-glu-oh ኦህ | 121343-82-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
99 | ኤች-ግሊ (ኦታቢ) -ሂህ.h2o | 2419-56-9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
100 | FMOC - የእሱ-ኦው | 116611-64-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
101 | ሰ - የእሱ (TTT) | 35146-32-8-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
102 | ቦክ-ኦ-ኦው | 17791-52-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
103 | Fmoc-les-ኦህ | 105047-45-88 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
104 | ኤች-ሊዎች (BOC)-ho | 2418-95-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
105 | ኤች-ሊዎች (አልሎክ) -ህ | 6298/3/9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
106 | FMOC-Orn-ኦ-ኦ-ኦ-ኦ-ኦ. ኤች.ኤል. | 201046-57-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
107 | ኤች - ኦን (ቦክ) -አ | 13650-49-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
108 | FMOC-SILE-ኦህ | 73724-45-5-5- | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
109 | ኤች-እባብ (ታውቡ) -ህ | 18822-58-7-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
110 | ኤች-SAT (TRT) -ህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
111 | Fmoc-hard-hy- ኦህ .ህ 2O | 73731-37-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
112 | ኤች-ሮብ (ታውቡ) -ህ | 4378-13-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
113 | FMOC-TRP- ኦው | 35737-15-16 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
114 | ኤች-TRP (BOC) -ህ | 146645-63-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
115 | FMOC-D-TRP-ኦህ | 861233-11-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
116 | HD-TRP (BOC) -ህ | እ.ኤ.አ.20090-11-1 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
117 | Fmoc-Tyr-ኦህ | 92954-0-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
118 | H-TYR (TABU) -..ሁ | 18822-59-88 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
119 | FMOC-D-TERR-ኦህ | 112883-29-1 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
120 | HD-TYR (et) | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
121 | H-Tyr (My)-ho.hcl | 67423-44-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
122 | FMOC-D-4 ah (CBM) -..ህ | 324017-22-32-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
123 | HD-4 ah (taruucbm) -ህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
124 | Fmoc-les (IRPS) -..ህ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
125 | ኤች-ሊስ (ኢ.ፒ.ፒ. | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
ካሳ
የጄቶሊክስ ከፍተኛ ጥራት ያላቸው ምርቶችን ያቀርባል, ማንኛውም የምርት ጥራት በደንበኛው በቂ ማስረጃዎች ካሉ በቂ ማስረጃዎች ጋር በተያያዘ በደንበኛው የተሻሻለ ከሆነ, የማካካቶች ሂደቶች ለማነሳሳት አስፈላጊ ትንታኔ እና ግምገማ እናቀርባለን.
ምርት
የመድኃኒት ምርቶች አቅም አቅማቸው ወደ 100 ምርቶች አቅም ላይ መድረስ, ችሎታው በዓለም ዙሪያ ደንበኞችን ለማገልገል በጥሩ ሁኔታ የተለመዱ ናቸው.
ምርምር እና ልማት
Targets ላማዎች በሚዘጋጁበት ጊዜ በየአመቱ የተለያዩ አዳዲስ ምርቶችን ለማዳበር በ R & D ቡድን የተዋቀረ እቅድ አውጥቷል.